29.10.2012 Views

Improved Synthesis of a Difficult Peptide by UV Monitoring

Improved Synthesis of a Difficult Peptide by UV Monitoring

Improved Synthesis of a Difficult Peptide by UV Monitoring

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Page 1 <strong>of</strong> 3<br />

Application Note BIO-0011<br />

<strong>Improved</strong> <strong>Synthesis</strong> <strong>of</strong> a <strong>Difficult</strong> <strong>Peptide</strong> <strong>by</strong> <strong>UV</strong> <strong>Monitoring</strong><br />

INTRODUCTION<br />

The AKR/Gross murine leukemia viruses (MuLV)<br />

are C-type retroviruses that cause the<br />

development <strong>of</strong> leukemia in AKR (H-2 k ) mice. 1<br />

Type-specific antiretroviral cytotoxic Tlymphocyte<br />

(CTL) responses have been<br />

reported that allow differentiation between<br />

infection <strong>by</strong> the AKR/Gross MuLV and other<br />

MuLV. 1 A 10-mer derived from the C-terminal<br />

portion <strong>of</strong> the AKR/Gross MuLV CTL epitope has<br />

been used as a model “difficult” peptide for this<br />

study because it cannot be synthesized under<br />

standard conditions. 2,3<br />

<strong>UV</strong> monitoring <strong>of</strong> Fmoc deprotection allows the<br />

optimization <strong>of</strong> difficult syntheses. Typically,<br />

Fmoc removal is accomplished with piperidine,<br />

although other reagents such as piperazine may<br />

also be used. Piperidine reacts with the Fmocprotected<br />

amino acid to remove the Fmoc<br />

group (which is converted to dibenz<strong>of</strong>ulvene)<br />

yielding the free amine following<br />

decarboxylation (Figure 1). The dibenz<strong>of</strong>ulvene<br />

can then react with piperidine to form the<br />

dibenz<strong>of</strong>ulvene-piperidine adduct (DBF-pip).<br />

Figure 1. Fmoc removal <strong>by</strong> piperidine.<br />

The DBF-pip molecule shows a distinct <strong>UV</strong><br />

absorbance at 301 nm that is easily discernible<br />

from the background absorbance <strong>of</strong> the other<br />

reagents present in the deprotection reaction.<br />

Thus, <strong>by</strong> monitoring the <strong>UV</strong> absorbance at 301<br />

nm, the relative efficiency <strong>of</strong> a given<br />

deprotection reaction can be measured.<br />

When the <strong>UV</strong> spectrometer is connected to the<br />

Liberty/Liberty1, all liquid waste from the<br />

deprotection step flows through the <strong>UV</strong> flow<br />

cell, and the absorbance is measured. If the<br />

absorbance detected after the second (3 min)<br />

deprotection is above the set threshold, the<br />

deprotection is considered failed, and<br />

additional 3 minute deprotections are<br />

performed until either a passing value is<br />

obtained or a maximum number <strong>of</strong><br />

deprotections has been reached.<br />

In theory, a difficult deprotection will<br />

correspond to a difficult coupling. When using<br />

the <strong>UV</strong> <strong>Monitoring</strong> Option, the coupling<br />

conditions can be modified (double coupling,<br />

extended coupling time, and/or capping) on<br />

failure to compensate for this difficulty.<br />

MATERIALS AND METHODS<br />

Reagents<br />

All Fmoc amino acids and O-(Benzotriazol-1-yl)-<br />

N,N,N’,N’-tetramethyluronium hexafluorophosphate<br />

(HBTU) were obtained from CEM<br />

Corporation. PAL-PEG-PS resin was obtained<br />

from Applied Biosystems (Carlsbad, CA).<br />

Diisopropylethylamine (DIEA), piperidine,<br />

trifluoroacetic acid (TFA), triisopropylsilane<br />

(TIS), and 3,6-dioxa-1,8-octanedithiol (DODT)<br />

were obtained from Sigma Aldrich (St. Louis,<br />

MO). Dichloromethane (DCM), N,N-dimethylformamide<br />

(DMF), N-methylpyrrolidone (NMP),<br />

anhydrous diethyl ether, acetic acid, HPLC grade<br />

water and acetonitrile were obtained from VWR<br />

(West Chester, PA).<br />

<strong>Peptide</strong> <strong>Synthesis</strong>:<br />

WFTTLISTIM-NH2<br />

The peptide was prepared using the CEM<br />

Liberty automated microwave peptide


synthesizer equipped with the <strong>UV</strong> <strong>Monitoring</strong><br />

option, on 0.500 g <strong>of</strong> PAL-PEG-PS resin (0.20<br />

meq/g substitution). Deprotection (20%<br />

piperidine) was performed in two stages with<br />

an initial deprotection <strong>of</strong> 30 s followed <strong>by</strong> 3 min<br />

at 75 °C. Coupling reactions were performed<br />

with 5 fold excess Fmoc-AA-OH with 1:0.9:2<br />

AA/HBTU/DIEA for 5 min at 75 °C. For syntheses<br />

with <strong>UV</strong> monitoring, deprotection and coupling<br />

conditions were modified on failure as shown in<br />

Table 1.<br />

Table 1. <strong>UV</strong> monitoring conditions.<br />

<strong>Synthesis</strong><br />

Page 2 <strong>of</strong> 3<br />

Number <strong>of</strong><br />

Deprotections (Max)<br />

30 s 3 min<br />

Double<br />

Couple<br />

on Fail<br />

Extended<br />

Coupling<br />

on Fail<br />

1 1 1 No No<br />

2 1 3 No 15 min<br />

3 1 3 Yes 15 min<br />

Cleavage was performed using 92.5% TFA/2.5%<br />

H2O/2.5% TIS/2.5% DODT for 30 min at 38°C.<br />

Following cleavage the peptide was precipitated<br />

and washed in diethyl ether. <strong>Peptide</strong>s were<br />

lyophilized in 10% acetic acid prior to analysis.<br />

<strong>Peptide</strong> Analysis<br />

The peptides were analyzed on a Waters<br />

Atlantis C18 column (2.1 ×150 mm) at 214 nm<br />

with a gradient <strong>of</strong> 5 – 70% MeCN with 0.1% TFA,<br />

0 – 20 min, with the column heated to 40 °C.<br />

Mass analysis was performed using an LCQ<br />

Advantage ion trap mass spectrometer with<br />

electrospray ionization (Thermo Electron).<br />

RESULTS<br />

The MuLV CTL peptide was first synthesized<br />

under standard microwave conditions, yielding<br />

a crude purity <strong>of</strong> 37%. Deletions <strong>of</strong> F, W, T, and<br />

WT were observed (Figure 2).<br />

Application Note BIO-0011<br />

Figure 2. <strong>Synthesis</strong> 1 (Standard Conditions)<br />

The peptide was resynthesized with <strong>UV</strong><br />

monitoring, with a maximum <strong>of</strong> three 3 min<br />

deprotections, and extended coupling time (15<br />

min) on failure.<br />

Failures were observed for Thr 3 and Phe 2 (Figure<br />

3a), accounting for the deletions <strong>of</strong> F and W<br />

respectively. Target was obtained at a crude<br />

purity <strong>of</strong> 33%. The deletion products observed<br />

without <strong>UV</strong> monitoring were still present<br />

(Figure 3b).<br />

Figure 3. <strong>Synthesis</strong> 2 (15 min coupling on failure).<br />

a. <strong>UV</strong> absorbance data (failures indicated <strong>by</strong> *).<br />

b. HPLC data.<br />

-WT -W -T<br />

-F<br />

-W<br />

-WT<br />

-F -T<br />

Target<br />

* *<br />

Target


Finally, the peptide was synthesized with a<br />

maximum <strong>of</strong> three 3 min deprotections, and<br />

double coupling and extended coupling time<br />

(15 min) on failure. Failures were observed for<br />

Leu 5 , Thr 3 , and Phe 2 (Figure 4a), accounting for<br />

the deletions <strong>of</strong> T, F, and W respectively. Target<br />

was obtained at a crude purity <strong>of</strong> 88%. The F<br />

and W deletions were minimized, and the T and<br />

WT deletions were eliminated (Figure 4b).<br />

Figure 4. <strong>Synthesis</strong> 3 (15 min double coupling on<br />

failure).<br />

a. <strong>UV</strong> absorbance data (failures indicated <strong>by</strong> *).<br />

b. HPLC data.<br />

CONCLUSION<br />

<strong>UV</strong> monitoring is a powerful tool for the<br />

optimization <strong>of</strong> peptide synthesis, allowing<br />

access to peptides that were previously difficult<br />

to synthesize at high purity.<br />

Page 3 <strong>of</strong> 3<br />

-W -F<br />

*<br />

* *<br />

Target<br />

Application Note BIO-0011<br />

REFERENCES<br />

1. Green, W. R. Immun. Rev. 1999, 168, 271-<br />

286.<br />

2. Redemann, T., Jung, G. <strong>Peptide</strong>s 1996. In<br />

Proceedings <strong>of</strong> the 24 th European <strong>Peptide</strong><br />

Symposium; Ramage, R., Epton, R., Eds.;<br />

Mayflower Scientific Ltd: Kingswinford, UK,<br />

1998; p 749.<br />

3. Carpino, L. A., et al. Tetrahedron Lett. 2004,<br />

45, 7519-7523.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!